These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 16713688)

  • 1. Differentiation between field and vaccine strain of bluetongue virus serotype 16.
    Monaco F; Cammà C; Serini S; Savini G
    Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of genome segments 2, 7 and 10 of bluetongue viruses serotype 2 for differentiation between field isolates and the vaccine strain.
    Bréard E; Sailleau C; Coupier H; Mure-Ravaud K; Hammoumi S; Gicquel B; Hamblin C; Dubourget P; Zientara S
    Vet Res; 2003; 34(6):777-89. PubMed ID: 14746772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.
    Batten CA; Maan S; Shaw AE; Maan NS; Mertens PP
    Virus Res; 2008 Oct; 137(1):56-63. PubMed ID: 18598726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Italian field and South African vaccine strains of bluetongue virus serotype 2 using real-time PCR.
    Orrù G; Santis PD; Solinas F; Savini G; Piras V; Caporale V
    J Virol Methods; 2004 Dec; 122(1):37-43. PubMed ID: 15488618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular differentiation of field and vaccine strains of bluetongue virus serotype 2 using the real-time polymerase chain reaction and fluorescene resonance energy transfer hybridisation probes.
    de Santis P; Orrù G; Solinas F; Piras V; Savini G; Caporale V
    Vet Ital; 2004; 40(4):572-6. PubMed ID: 20422589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP2-segment sequence analysis of some isolates of bluetongue virus recovered in the Mediterranean basin during the 1998-2003 outbreak.
    Potgieter AC; Monaco F; Mangana O; Nomikou K; Yadin H; Savini G
    J Vet Med B Infect Dis Vet Public Health; 2005 Nov; 52(9):372-9. PubMed ID: 16283915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of real-time RT-PCR as a rapid molecular approach for differentiation of field and vaccine strains of bluetongue virus serotypes 2 and 9.
    Elia G; Savini G; Decaro N; Martella V; Teodori L; Casaccia C; Di Gialleonardo L; Lorusso E; Caporale V; Buonavoglia C
    Mol Cell Probes; 2008 Feb; 22(1):38-46. PubMed ID: 17693055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of bluetongue virus in Portugal during 2004-2006 outbreak.
    Barros SC; Ramos F; Luís TM; Vaz A; Duarte M; Henriques M; Cruz B; Fevereiro M
    Vet Microbiol; 2007 Sep; 124(1-2):25-34. PubMed ID: 17521832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
    Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
    Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bluetongue: characterization of virus types by reverse transcription-polymerase chain reaction.
    Zientara S; Bréard E; Sailleau C
    Dev Biol (Basel); 2006; 126():187-96; discussion 326-7. PubMed ID: 17058494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First evidence of bluetongue virus serotype 16 in Croatia.
    Listes E; Monaco F; Labrović A; Paladini C; Leone A; Di Gialleonardo L; Cammá C; Savini G
    Vet Microbiol; 2009 Jul; 138(1-2):92-7. PubMed ID: 19376658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
    Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
    Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bluetongue virus serotypes 1 and 4 in Sardinia during autumn 2012: new incursions or re-infection with old strains?
    Lorusso A; Sghaier S; Carvelli A; Di Gennaro A; Leone A; Marini V; Pelini S; Marcacci M; Rocchigiani AM; Puggioni G; Savini G
    Infect Genet Evol; 2013 Oct; 19():81-7. PubMed ID: 23838283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
    Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
    Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serogrouping of United States and some African serotypes of bluetongue virus using RT-PCR.
    Aradaib IE; Mohamed ME; Abdalla TM; Sarr J; Abdalla MA; Yousof MA; Hassan YA; Karrar AR
    Vet Microbiol; 2005 Dec; 111(3-4):145-50. PubMed ID: 16280207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.